TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 44 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $53,000 | +381.8% | 56,000 | +366.7% | 0.00% | – |
| Q3 2019 | $11,000 | -77.6% | 12,000 | -77.4% | 0.00% | – |
| Q1 2019 | $49,000 | -94.5% | 53,000 | -94.7% | 0.00% | -100.0% |
| Q1 2018 | $890,000 | -59.8% | 1,000,000 | -50.5% | 0.01% | -58.3% |
| Q4 2016 | $2,216,000 | -63.3% | 2,021,000 | -47.5% | 0.01% | -64.7% |
| Q4 2015 | $6,046,000 | +237.2% | 3,852,000 | +191.4% | 0.03% | +240.0% |
| Q3 2015 | $1,793,000 | +248.8% | 1,322,000 | +251.6% | 0.01% | +233.3% |
| Q4 2014 | $514,000 | -73.9% | 376,000 | -79.7% | 0.00% | -76.9% |
| Q4 2013 | $1,970,000 | – | 1,855,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Asset Management Company, LLC | 31,076,000 | $29,006,000 | 23.36% |
| INCOME RESEARCH & MANAGEMENT | 15,589,000 | $14,254,000 | 7.13% |
| SYMPHONY ASSET MANAGEMENT LLC | 17,600,000 | $16,378,000 | 5.14% |
| PenderFund Capital Management Ltd. | 8,470,000 | $11,097,000 | 3.46% |
| Radcliffe Capital Management, L.P. | 15,823,000 | $14,645,000 | 2.75% |
| LMR Partners LLP | 34,735,000 | $32,172,000 | 1.50% |
| Bracebridge Capital, LLC | 5,500,000 | $5,000,000 | 0.91% |
| Penn Capital Management Company, LLC | 5,079,000 | $4,701,000 | 0.78% |
| ONTARIO TEACHERS PENSION PLAN BOARD | 17,400,000 | $16,191,000 | 0.44% |
| WESTWOOD HOLDINGS GROUP INC | 29,605,000 | $27,715,000 | 0.42% |